Scientific Program - THURSDAY

Print

THURSDAY, APRIL 16, 2015
Hall Tiergarten 1
07:00-08:00
Chinese Diabetes & Pregnancy Study Group
THE GDM MINISTRY OF HEALTH CHINA----WDF PROJECT
Chairpersons: Huixia Yang, China; Xianming Xu, China; Anil Kapur, India
07:00-07:15  Gestational diabetes in China: Challenges and coping strategies
Huixia Yang, China 
   
07:15-07:23 Fetal growth is associated with maternal fasting plasma glucose at first prenatal visit
Zilian Wang, China
   
07:23-07:28 Gestational weight gain and diabetes
Xianming Xu, China
   
07:28-07:33 The management of gestational diabetes mellitus in maternity hospital
Jianxia Fan, China
   
07:33-07:38 GDM current situation and coping strategies in the southwest of China
Xinghui Liu, China
   
07:38-07:43 The prevalence and risk factors of gestational diabetes mellitus in Beijing
Weiwei Zhu, China
   
07:43-07:48 Maternal birth weight predict overweight in children from mothers with gestational diabetes
Rina Su, China
   
07:48-07:53 Study on mechanism of offspring exposed to intrauterine hyperglycemia
Jie Yan, China
   
07:53-08:00 Conclusion
Xianming Xu, China
Hall Tiergarten 3
 08:00-09:00
Indian Diabetes & Pregnancy Study Group
Chairpersons: Anil Kapur, India; Hema Divakar, India
  Screening and diagnosis in low resource settings:
What has been done? What is desired?
   
  Materno fetal surveillance in GDM:
From reports to action
   
 
GDM opportunities for action:
Achieving targets before next pregnancy
   
Hall Tiergarten 2 
08:00-09:30
European Working Group of Abnormally Invasive Placenta
ABNORMALLY INVASIVE PLACENTA – THE EUROPEAN APPROACH
Moderators: Wolfgang Henrich, Charité University Berlin, Germany & Boris Tutschek, Heinrich Heine University Duesseldorf
  Basics/Epidemiology
Johannes Duvekot, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands
   
  Diagnostics
Sally Collins, The Women´s Centre John Radcliffe Hospital, Oxford, United Kingdom & Olivier Morel, Maternité Regionale University de Nancy, France
   
 
Management
Jens Langhoff-Roos, Ringshospitalet, Copenhagen University, Denmark &
Wolfgang Henrich and Thorsten Braun, Charité University Berlin
   
  EW-AIP Research
Frederic Chantraine, University de Liège, Liège, Belgium
HALL A
Session 5
08:00-09:30
Guten Morgen Berlin
SETTING THE CONGRESS SCENE:
THE GREAT OBSTETRICAL SYNDROMES (GOS) AND THE OMICS
Chairpersons: Luis Cabero Roura, Spain; Kurt Hecher, Germany  
08:00-08:20
The Great Obstetrical Syndromes – Predictable and Preventable?
Kypros Nicolaides, UK
 
08:20-08:40
Metabolomics and the Great Obstetrical Syndromes
Vassilios Fanos, Italy
   
08:40-09:00
Mircrobiomics and the Great Obstetrical Syndromes – A New Frontier
Fionnuala McAuliffe, Ireland
   
09:00-09:20
Genomics and the Great Obstetrical Syndromes – small RNAs
Noam Shomron, Israel 
   
09:20-09:30 Discussion
   
09:30-10:00
Coffee Break  (Exhibition Area)
   
Hall A
Session 6
10:00-12:00
THE HOTTEST TOPICS ON THE SCENE
Chairpersons: Ute Schäfer-Graf, Germany; Donald R. Coustan, USA
10:00-10:20
Perinatal programming - the role of Epigenetics
Mark Hanson, UK
   
10:20-10:40
Perinatal programming - the role of maternal Microbiome
Omry Koren, Israel
   
10:40-11:00
Perinatal programming of type 1 diabetes
Anette Ziegler, Germany
   
11:00-11:20
Does Type I childhood diabetes start in utero?
Zvi Laron, Israel
   
11:20-11:40
Obesity or Diabetes; which is more hazardous to the mother and offspring?
Oded Langer, USA
   
11:40-12:00
Complications and costs associated with diabetes and pregnancy: A retrospective analysis
Lois Jovanovic, USA
   
12:00-13:00
Lunch Break (Exhibition Area)
Hall Charlottenburg 3
12:00-13:00
Oral E-Poster Presentations
5 minutes/5 slides
Chairperson: Rony Chen, Israel
12:00-12:05
Determining obstetrical and perinatal outcome among GDM patients by gestational age at delivery
Amir Aviram, Israel
12:05-12:10
Endothelial dysfunction markers and uterine vascularization in gestational diabetes
Fernando Bugatto, Spain
12:10-12:15
Targeted sequencing of GCK, HNF4A, HNF1A, HNF1B AND INS in women with previous gestational diabetes reveals a high frequency of maturity onset diabetes of the young
Line Engelbrechtsen, Denmark
12:15-12:20
Effect of probiotic supplements daily consumption on the metabolic profile and weight changes among pregnant women with gestational diabetes mellitus: a randomized clinical trial
Neda Dolatkhah, Iran
12:20-12:25
Random plasma glucose (RPG) in early pregnancy can predict gestational diabetes (GDM)
Claire Meek, UK
12:25-12:30
Macronutrient intake and gestational diabetes in obese women
Laura Mullaney, Ireland
12:30-12:35
Adipose tissue adiponectin expression and its relation to metabolic and endocrine parameters in women with gestational diabetes and their offspring
Rebecca Rancourt, Germany
12:35-12:40
Gestational diabetes mellitus (GDM) occurrence in overweight/obese women undergoing early pregnancy lifestyle program
Elisabetta Petrella, Italy
12:40-12:45
Third trimester sonograms in gestational diabetes: is one enough?
Ana Regalo, Portugal
12:45-12:50
Altered vascular endothelial growth factor (VEGF) and soluble FMS-like tyrosine kinase-1 (SFLT-1, VEGFR-1) cord serum concentrations in gestational diabetes mellitus (GDM)
Klara Rosta, Austria
12:50-13:00 Discussion
   
in parallel
Hall Tiergarten 1
12:00-13:00
Meet the Experts Lunch Session 1
Pre-registration required by April 1, 2015
12:00-12:40 
Pro and con for the IADPSG criteria for GDM
Donald R. Coustan, USA & Boyd E. Metzger, USA
12:40-13:00 Q&A and Discussion
   
in parallel
Hall- TBA
12:00-13:00
 Meet the Expert Lunch Session 2
Pre-registration required by April 1, 2015
12:00-12:40  
Should we stop doing triple test?
Howard Cuckle, UK
   
12:40-13:00 Q&A and Discussion
   
in parallel
Hall Tiergarten 2
12:00-13:00
 Meet the Expert Lunch Session 3
Pre-registration required by April 1, 2015
12:00-12:40  
Late IUGR
Gerard Visser, The Netherlands
   
12:40-13:00 Q&A and Discussion
   
in parallel
Hall Tiergarten 3
12:00-13:00
 Meet the Expert Lunch Session 4
Pre-registration required by April 1, 2015
12:00-12:40  
It is all in the microbiome
Omry Koren, Israel
   
12:40-13:00 Q&A and Discussion
   
in parallel
Hall Charlottenburg 1 & 2
 Luncheon Session
12:00-13:00 
INFECTIOUS DISEASE IN OBSTETRICS
(Registration Closed)
Chairpersons: Gian Carlo Di Renzo, Italy; Katharina Von Weizsäcker, Germany
12:00-12:15
The Epidemiology of GBS
Katharina Von Weizsäcker, Germany
   
12:15-12:30 Screening for GBS colonization: Old and new tools
Pierrette Melin, Belgium
   
12:30-12:45 New technologies: Should we screen at 35-37 weeks or diagnose intrapartum
Eran Hadar, Israel
   
12:45-13:00 The European Consensus on GBS screening and prevention
Gian Carlo Di Renzo, Italy
 

Hall A
 Session 7 13:00-15:00
FIGO-GDM INITIATIVE- TOWARDS A UNIVERSAL CONSENSUS ON GDM DIAGNOSIS
THE VOICE OF THE INTERNATIONAL ORGANIZATIONS
Chairpersons: Boyd E. Metzger, USA, HAPO Study ; Sabaratnam Arulkumaran, UK, FIGO President

13:00-13:15

The voice of FIGO- moving from controversies to consensus
C.N. Purandare, India, FIGO President Elect
   
13:15-13:30
Rationalizing maternal and Neonatal Care- EBCOG approach
Tahir Mahmood, UK, EBCOG President
   
13:30-13:45
GDM– an end to procrastination and a time for action- The IADPSG voice
David McIntyre, Australia, IADPSG President
   
13:45-14:00
Gestational diabetes mellitus in China: difficulties and coping strategies
Huixia Yang, China
   
14:00-14:15
GeDiForCE Model
Elliot Marseille, USA
   

14:15-14:30

Health system and societal barriers in improving diabetes related maternal health
Anil Kapur, India
   
 14:30-14:45 The FIGO-GDM Initiative Project
Moshe Hod, Israel, EAPM President Elect, FIGO-GDM Expert Group Chairman
   

14:45-15:00

Discussion
   
15:00-15:30 Coffee Break (Exhibition Area)
   
Hall A
Session 8
15:30-17:00
HYPERTENSION IN PREGNANCY: PREDICTION AND PREVENTION
Chairpersons: Jacob Bar, Israel; Stefan Verlohren, Germany
15:30-15:45
The pathogenesis of preeclampsia: Clues to prevention and treatment
Michael Paidas, USA
   

15:45-16:00

More than a decade of angiogenic factors– What has been done, what still needs to be done?
S. Ananth Karumanchi, USA
   

16:00-16:15

Extracorporeal removal of sFlt-1 – a new therapy
S. Ananth Karumanchi, USA
   
16:15-16:30
PROGNOSIS Study
Stefan Verlohren, Germany
   
16:30-16:45
PreOS Study - Preeclampsia open study
Holger Stepan, Germany
   
16:45-17:00
Is it really all about angiogenic factors? What are the health economic implications?
Jacob Bar, Israel
   
Hall A
Session 9
17:00-18:30
PERINATAL MEDICINE AND THE INDUSTRY–
STATUS AND FUTURE DIRECTIONS
Chairpersons: Wolfgang Holzgreve, Germany; Klaus Vetter, Germany
17:00-17:15
Setting the scene: How can the Pharma Industry contribute to public health?
Orit Jacobson, Israel
 
 
17:15-17:30
Diabetes in pregnancy and the insulin industry
Soraya Ramoul, Denmark
 
 
17:30-17:45 Predictions of maternal fetal complications
Yvonne Parker, UK
 
 
17:45-18:00
Maternal and fetal nutrition
Eline M. van der Beek, The Netherlands
 
 
18:00-18:15
Innovative data driven approach in drug safety; Real world research utilizing Social Media and EMRs as a source
Ran Balicer, Israel
   
18:15-18:30
Discussion